US Patent Issued to Massachusetts Institute of Technology on Aug. 12 for "Cyclin-dependent kinase 5 (CDK5) inhibitory peptides" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,818, issued on Aug. 12, was assigned to Massachusetts Institute of Technology (Cambridge, Mass.).

"Cyclin-dependent kinase 5 (CDK5) inhibitory peptides" was invented by Li-Huei Tsai (Cambridge, Mass.) and Jinsoo Seo (Worcester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods and compositions for promoting cognitive function and/or treating cognitive function disorders and impairments. In particular the methods are accomplished by administering to a subject a specific CDK5 peptide inhibitor and a pharmaceutically acceptable carrier."

The patent was filed on Aug. 31, 2018, under Application No. 16/119,656.

*For ...